Healthcare professionals attend to a patient in front of a PrisMax System

A Diverse Portfolio of CRRT Solutions

Vantive addresses the needs of patients experiencing acute kidney injury with a wide range of purposefully designed CRRT solutions.

 

 

Solutions to address specific clinical challenges 

Vantive CRRT solutions enable clinicians to treat acid-base and electrolyte disorders, treatment-related disturbances in electrolyte homeostasis and clotting in the extracorporeal circuit. 

Bicarbonate-buffered-solutions-range

Bicarbonate-buffered solutions

We offer a range of bicarbonate-buffered CRRT solutions, available in various formulations.

Regiocit-Prismocitrate bag

Solutions for regional citrate anticoagulation

We offer a low-concentration citrate solution that provides regional anticoagulation to patients with high bleeding risk.

Focus on patient care with simplified therapy delivery and improved efficiencies

Our pre-mixed CRRT solutions are designed to reduce the potential of preparation errors associated with pharmacy-made solutions and the related liability — while improving efficiencies. Pre-mixed solutions may also help streamline processes, minimize pharmacy compounding costs, reduce the nursing burden associated with separately administering electrolytes, and help improve workflow efficiencies for the hospital.1-5

Important Safety Information

Please click here for important safety information.

Vantive is a trademark of Vantive Health LLC or its affiliates.

References

  1. Besnard N, Serveaux M, Machado S, et al. Electrolytes-enriched hemodiafiltration solutions for continuous renal replacement therapy in acute kidney injury: a crossover study. Blood Purif. 2016;42(1):18-26. 

  2. Godden J, Spexarth F, Dahlgren M. Standardization of continuous renal-replacement therapy fluids using a commercial product. Am J Health Syst Pharm. 2012;69(9):786-793. 

  3. Barletta JF, Barletta GM, Brophy PD, Maxvold NJ, Hackbarth RM, Bunchman TE. Medication errors and patient complications with continuous renal replacement therapy. Pediatr Nephrol. 2006;21(6):842-845.

  4. Shaw AR, Chaijamorn W, Clark JS, Mueller BA. Preparation times and costs for various solutions used for continuous renal replacement therapy. Am J Health Syst Pharm. 2018;75(11):808-815.

  5. ​Jang S, et al. Am J Health-Syst Pharm. 2018 Jul 1;75(13):931-932.